Pregnancy Hypertension-An International Journal of Womens Cardiovascul

Article	Citations
Comparison of subfoveal choroidal thickness in patients with hypertensive disorder of pregnancy versus normotensive pregnant women in third trimester of pregnancy	54
GSTP1-A313G genetic polymorphism and the risk of preeclampsia in pregnant women: A study in the northern population of Iran	32
Six-week blood pressure trends in postpartum patients utilizing remote patient monitoring program	30
Sociodemographic risk factors associated with patient follow-up after implementation of a CardioObstetrics program	27
PO8_1. CANCELLED : Predictive value of longitudinal maternal serum angiogenic marker assessment for maternal adverse outcomes in pregnancies with preeclampsia	26
PO1_20. Midtrimester drop in bp is not associated with a decreased risk for hypertensive disorder of pregnancy in a nulliparous cohort	25
OP14_5. Metformin to prolong pregnancy in preterm preeclampsia	24
PO6_15. Predictive utility for preeclampsia of the SFLT-1/PLGF ratio test in routine clinical practice: a retrospective analysis of 1,397 pregnancies with suspected pre-eclampsia	24
OP15_4. A biopolymer-fused form of placental growth factor for treatment of preeclampsia	21
PO6_19. The diagnostic accuracy of American college of cardiology/American heart association blood pressure categories for identification of women and babies at risk of adverse pregnancy outcomes – a	21
Perceptions and experiences of blood pressure self-monitoring during hypertensive pregnancy: A qualitative analysis of women’s and clinicians’ experiences in the OPTIMUM-BP trial	18
Efficacy of B7-33 peptide in attenuating preeclampsia symptoms in rat models	18
Examining changes in clinical management and postpartum readmissions for hypertensive disorders of pregnancy over time	18
New 3D cardiac in vitro models for assessing the maternal cardiovascular health five years post hypertensive disorders of pregnancy	18
Fetal growth and Doppler abnormalities associated with antenatal bisoprolol exposure	17
Cardiometabolic health 8–12 years after pre-eclampsia: Role of obesity and gestational diabetes (FINNCARE study)	16
Implementation and uptake of calcium and aspirin for prevention of preeclampsia in Malawi; Post trial views and recommendations of health care workers	16
Comparison of Zuspan regimen and its 12-hour modification in women with severe pre-eclampsia and eclampsia in two hospitals in Abeokuta	15
Short communication: Is there any benefit of initiating aspirin before the 11th week of gestation?	14
Association of MTHFR C677T and A1298C variants with preeclampsia risk and angiogenic imbalance in Tunisian women	14
Extended postpartum outcomes with systematic treatment of and management of postpartum hypertension program	14
The sFLT-1/PlGF ratio versus biochemical parameters in prediction of adverse outcomes in preeclamptic women	14
Title Page	13
Maternal death associated with preeclampsia in Indonesia	13
PO7_3. Patient perception of home blood pressure monitoring kits	13

PO2_08. decreased sodium (NA + ) buffer capacity in pregnancy and in women following pre-eclampsia	13
Pregnancy outcomes and ambulatory blood pressure monitoring characteristics in women with high-normal blood pressure during pregnancy	11
Optoacoustic imaging reveals preserved placental oxygen saturation in a mouse model of preeclampsia	11
Slow early β-hCG elevation is associated with increased risk for hypertensive pregnancy complications	10
Management of hypertension in the early postpartum: A randomized controlled trial	10
Examining the impact of preeclampsia on the likelihood of developing cardio, renal, and cerebrovascular (CRCV) disease using predictive biomarkers	10
Correlation between morning hypertension and perinatal outcomes in patients with hypertensive disorders of pregnancy	10
Conformation-dependent anti-Aβ monoclonal antibody signatures of disease status and severity in urine of women with preeclampsia	10
Letter to the editor: Detection of hypertension and blood pressure phenotypes using ambulatory blood pressure monitoring in women with past hypertensive disorders of pregnancies	9
Perinatal outcomes and their determinants among women with eclampsia and severe preeclampsia in selected tertiary hospitals, Eastern Ethiopia	9
PO9_05. Endothelial glycocalyx dysfunction in early- and late-onset preeclampsia	9
Rubidium – Initial observations of an enigmatic element in pre-eclampsia	9
The P4 Study: 6 months postpartum body composition in normotensive vs hypertensive pregnancies	9
PO7_1. Patient perceptions regarding remote patient monitoring for postpartum hypertension	9
Validation of the fullPIERS model in a tertiary hospital in southern Brazil	9
OP14_4. Epigenetic regulation by STOX1 in trophoblast cells lines	9
Peripartum antihypertensive use and the risk of neonatal hypoglycemia and postpartum uterine atony: a retrospective cohort study	9
PO4_2. Genome-wide association study sheds more light on the pathophysiology of preeclampsia	9
Case of chorioamnionitis in ANA positive in second trimester of pregnancy	9
Association between serum NfL and NfH with Antepartum and Postpartum Hypertension	8
WITHDRAWN: COVID-19 not hypertension or diabetes increases the risk of preeclampsia among a high-risk population	8
Does Brazil need a fullPIERS model adapted to its population?	8
Neuroimaging in eclampsia: A window into the correlates between neural pathology and maternal outcomes	8
Validation of urinary Congo Red preeclampsia detection point-of-care devise	8
Acceptability of WhatsApp-based conversational messaging for remote blood pressure monitoring in pregnancy: Beta testing in women with lived experience of pregnancy hypertension	8
Proteinuria in severe preeclampsia: Clinical significance in modern obstetrics	8
The role of uterine artery perivascular adipose tissue in preeclampsia: insights from the obese and preeclamptic-like BPH/5 mouse model	8
Home blood pressure monitoring and mobile health application practices among pregnant persons with and at risk of hypertensive disorders of pregnancy	8
Perfluorooctane sulfonic acid increases blood pressure and disrupts vascular function and placental steroidogenesis in pregnant rats	7
Secondary hyperaldosteronism due to renal agenesis: Rare cause of secondary hypertension in pregnancy	7
PO7_4. Short animated videos aimed at the greatest number of women, to allow and promote self-care in preeclampsia	7
PO1_04. Innovative use of Robson classification to understand prevalence of preeclampsia: findings from a Brazilian survey	7
PO2_07. Metabolic outcomes in women six months and two years after hypertensive versus normotensive pregnancy – a P4 study	7
Smaller decrease in late second trimester blood pressure is associated with gestational hypertensive disease development	7
PO2_14. Impact of previous hypertensive disorders during pregnancy on long-term cardiovascular consequences in women with severe hypertension	7
History of IgA vasculitis with nephropathy (Henoch-Schonlein purpura nephritis) can be a strong risk factor for preeclampsia	7
PO9_13. Towards ‘the best method to determine proteinuria’ in pregnant women	7
PO6_21. The utility of the SFLT-1/PLGF ratio among patients with or without hypertension who are suspected of having preeclampsia	7
Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia	7
PO6_06. Soluble endoglin versus SFLT-1/PLGF ratio: detection of preeclampsia, hellp syndrome and FGR in a high-risk cohort	7
PO3_11. Elective anticipation of delivery in preeclampsia with cervical preparation by prostaglandins: success for vaginal delivery	7
PO3_09. Inhibition of arginase and supplementation with folic acid decrease ROS production in endothelial cells incubated with plasma from preeclampsia pregnant	7
Comparison of double-filtration plasmapheresis (DFPP) versus heparin-mediated extracorporeal LDL-precipitation (HELP)-apheresis in early-onset preeclampsia	6
Exposure to higher concentrations of exogenous ELABELA causes HTR-8/SVneo trophoblast cell dysfunction: A possible pathogenesis of pre-eclampsia	6
The unintended consequences of modernity: Pollution and its effect on reproductive, maternal and fetal health	6
Signs or symptoms of suspected preeclampsia – A retrospective national database study of prevalence, costs, and outcomes	6
Validation of the Finnish Care register for Health Care diagnoses for preeclampsia, gestational diabetes and preterm delivery	6
Nifedipine outperforms labetalol: A comparative analysis of hypertension management in black pregnancies	6
PLGF – A pioneer in prediction of pre - eclampsia	6
OP04_5. Risk for cardiovascular and cerebrovascular diseases in women during first ten years after pre-eclampsia pregnancy in the FINNPEC study	6

First trimester preeclampsia screening and risk of placental lesions	6
Determining the relationship between severity of proteinuria and adverse maternal and neonatal outcomes in patients with preeclampsia	6
Operationalising the broad definition of pre-eclampsia	6
Preeclampsia and eclampsia: Its burden and distribution across facilities in Ethiopia	6
Structural variations in immunoglobulin and T cell receptors variable regions in preeclampsia and HELLP syndrome	6
Eplerenone: A candidate drug to mitigate long-term maternal vascular dysfunction following preeclampsia	5
Impact of antenatal SARS-CoV-2 infection on development of hypertensive disorders of pregnancy in a large, diverse, cohort	5
Editorial Board	5
PO8_4. Late postpartum eclampsia with multifocal posterior reversible encephalopathy syndrome after twin gestation: a case report	5
Women’s perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia	5
Barriers and facilitators for adequate calcium intake during pregnancy: A mixed methods study	5
First trimester screening (FTS) for placental pathology – Comparison of the efficacy of different methods	5
Impact of Maternal Early Warning Trigger (MEWT) tool on the incidence of eclampsia	5
Water-pipe tobacco and cigarette smoking, on preeclampsia: adverse or protective effect: MATCH cohort study	5
Burden and determinants of preeclampsia and eclampsia in Ugandan tertiary healthcare facilities: a systematic review	5
PO6_20. The SFLT-1/PLGF ratio for the prediction of preeclampsia-related adverse fetal and maternal outcomes in women with preexisting diabetes	5
Increased adherence to ACOG diagnostic guidelines for HDP following a workshop in Bolivia, a LMIC	5
Maternal and neonatal outcomes according to delivery route in early preeclampsia: a systematic review and meta-analysis	5
Assessing the Mediterranean diet adherence during pregnancy: Practical considerations based on the associations with cardiometabolic risk	5
A multi-ancestry genome-wide association study identifies novel candidate loci near the RARB gene associated with hypertensive disorders of pregnancy in the personalized environment and genes study	5
Diagnostic challenges of Thrombotic Microangiopathy (TMA) in a pregnant woman remote from term and a case report of atypical TTP	5
Persistence of abnormal uterine artery flow postpartum: Case-control study	5
OP08_2. New generation antiplatelet therapies decrease soluble FMS-like tyrosine kinase-1, enhance antioxidant cytoprotection, rescue vascular and endothelial dysfunction and decrease hypertension in	5
Reference-range of arterial stiffness by cardio-ankle vascular index in normal pregnancy	5
PO1_03. Individual, social, and environmental risk factors for hypertensive disorders of pregnancy in Ghana: A systematic review	5
A study of long-term prognosis after delivery in patients with hypertensive disorders of pregnancy	5
PO3_10. CANCELLED : A randomized controlled trial comparing low doses of aspirin in the prevention of preeclampsia (ASAPP): the first 100 patients	4
PO2_06. Lymphatic mimicry of endothelial cells in utero-placental spiral arteries is impaired by overexpression of HSFLT1 in a murine model for preeclampsia	4
Residual liver stiffness in the postpartum period in women with preeclampsia and healthy women: A case-control study	4
Divergent profiles in early and late postpartum preeclampsia	4
Cardiovascular morbidity and mortality following hypertensive disorders of pregnancy	4
(Withdrawn)	4
PO1_16. Changes in early pregnancy blood pressure among nulliparas that developed a hypertensive disorder of pregnancy	4
OP15_5. Metformin to treat preeclampsia: mechanism of action influences mitochondrial dynamics	4
OP05_4. Umbilical cord plasma from women with pre-eclampsia reduces brain endothelial cell migration involving alterations in the VEGFR2-COFILIN-F-ACTIN polymerization pathway	4
Maternal pulmonary hypertension and cardiopulmonary outcomes during delivery hospitalization in the United States: A nationwide study from 2016–2020	4
Hypertensive disorders of pregnancy in women with autoimmunity: A rising incidence?	4
Letter to the editor: Is there a relationship between visit-to-visit blood pressure variability and adverse perinatal outcomes?	4
PO8_3. Investigating the role of biomarkers (SFLT-1/PLGF) in cases of covid-19 and its use to distinguish preeclampsia and guide clinical management	4
OP05_5. Characterization of prokineticins receptors anatagonization in preeclampsia: in vitro and in vivo studies	4
Placental-brain mechanisms underlying maternal brain and behavior changes in preeclampsia	4
Maternal social deprivation and risk of preeclampsia	4
Uterine artery doppler as prognostic indicator in Fetal growth restriction in third trimester	4
SC3_3. FKBPL signalling in placental development and preeclampsia	4
Perinatal AT1-AA exposure causes hypertension during pregnancy in first generation female offspring	4
Artificial Intelligence-based analysis of pre-eclampsia gene expression profiles for identification of novel potential pre-eclampsia diagnostic biomarkers	3
Failed cardiac adaptations to pregnancy are associated with placental insufficiency and fetal growth restriction in the Pregnant Dahl SS model of superimposed preeclampsia	3
Is a sFlt-1/PlGF cutoff of 38 suitable to predict adverse outcomes in pregnancies with abnormal uterine artery Doppler velocimetry in the second trimester?	3
Blood pressure measurement and adverse pregnancy outcomes – Testing alternatives to 140/90 mmHg	3
New cardiac platform for the management of cardiovascular risk following preeclampsia using in vitro bioengineered cardiac spheroids and patient-derived stem cells	3
Cardiovascular remodelling and reverse remodelling during pregnancy and postpartum: Looking at the right side	3
Socioeconomic factors impacting aspirin adherence and preeclampsia development in high-risk pregnant patients	3
Association of fetal sex with angiogenic factors in normotensive and hypertensive pregnancy states	3
PO9_07. CANCELLED : Grading the severity of early-onset preeclampsia using parameters considered for indication for delivery: a Delphi consensus	3
Letter to the editor: Caution: Not all sFlt-1/PlGF ratios are the same	3
Bioprinting a placental model to study the effects of current and emerging treatments of preeclampsia	3
Title Page	3
Imbalanced expression of TNFR1 and TNFR2 in monocyte subset indicates impaired immune regulation in preeclampsia	3
Detection of hypertension and blood pressure phenotypes using ambulatory blood pressure monitoring in women with past hypertensive disorders of pregnancies	3
PO1_19. Maternal Mortality from Hypertension in Pregnancy in Brazil from 2015 to 2019	3
Perspectives of Ghanaian pregnant women on family involvement in home blood pressure Monitoring: A qualitative analysis	3
Cardiovascular mortality risk a decade after twin and singleton pregnancies complicated by hypertensive disorders of pregnancy	3
The epidemiology of pregnancy hypertension in three sub-Saharan African countries: the precise prospective cohort study	3
Preeclampsia, gestational hypertension and incident dementia: A systematic review and meta-analysis of published evidence	3
OP09_1. Prepare: a stepped wedge cluster randomised trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia	3
OP06_5. Alcohol exposure prior to pregnancy - does risk consumption increase the risk of preeclampsia and low birth weight? a swedish population-based cohort study	3
Self antenatal monitoring of blood pressure at home as interVention ( SAMBHAV) in hypertensive women: Challenges in the developing country	3
Improving treatment of severe hypertension in pregnancy and postpartum using a hypertensive pathway	3
Preeclampsia in women with lupus – Influence of aspirin and hydroxychloroquine on pregnancy outcome	3
Analyses of selected tumour-associated factors expression in normotensive and preeclamptic placenta	3
Placental transcriptomics reveals molecular heterogeneity of preeclampsia in twin gestations	3
Self-monitoring blood pressure in Pregnancy: Evaluation of health professional experiences of the BUMP trials	3
Gestational weight gain among gravidae with hypertension receiving labetalol versus nifedipine	3
Postnatal antihypertensives regimens, blood pressure trajectories and readmission after hypertensive disorders of pregnancy	3
PO1_10. Incidence of prematurity in pregnancies complicated by hypertensive syndromes: A systematic review	3
No association in maternal serum levels of TMAO and its precursors in pre-eclampsia and in non-complicated pregnancies	3
Hypertension and diabetes risk in patients with previous pregnancy-related disorders and the time to onset of the disease	3
Title Page	2
SSRI use in pregnancy: Moving towards collaborative, evidence-based decision-making	2
OP06_4. Circulating concentrations of glyxocalyx degradation products in preeclampsia	2

PO2_10. CANCELLED: Maternal vascular malperfusion lesions and preeclampsia are associated with microvascular dysfunction, worse cognition and circulating angiogenic biomarkers 8-10 after pregnancy	2
Title Page	2
PO9_17. Interventions for improving subject enrollment in RCT	2
Role of chronic kidney disease and risk factors in preeclampsia	2
The impact of maternal chronic hypertension in pregnancy on offspring long-term respiratory morbidity	2
Preliminary baseline data from the NIT_CH trial: sociodemographic and biochemical profile of pregnant women with chronic hypertension	2
Pre-eclampsia risk-stratified planned birth at term – Women’s perspectives on acceptability and risk communication	2
Preconception vitamin D status and subsequent risk of preeclampsia: A secondary cohort analysis from the EAGeR trial	2
A tribute to Christopher Redman, MB, BChir, FRCP, FRCOG (ad eundum)	2
Impact of pregnancy on hypertension and cardiovascular risks among reproductive aged Congolese women: Insights from the 2019 to 2024 May measurement month surveys	2
OP07_4. Aspirin treatment improves reduced uterine perfusion pressure (RUPP)-induced cardiac dysfunction in pregnant rats	2
The significance of mitochondrial haplogroups in preeclampsia risk	2
Racial differences in healthcare utilization among patients with suspected or diagnosed preeclampsia: A retrospective cohort study	2
Prognostic significance of liver function tests in predicting maternal and fetal outcomes in Hypertensive Disorders of Pregnancy	2
Postpartum readmissions for hypertension in patients discharged on Labetalol and Nifedipine in a Tertiary Care Centre in South India	2
Reduced syncytiotrophoblast-glycocalyx expression is associated with placental malperfusion and the severity of late-onset preeclampsia	2
Maternal C1q deficiency leads to impaired hemodynamic adaptations and cardiovascular dysfunction during pregnancy	2
PO6_11. Clinical value and cost analysis of the SFLT-1/PLGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected preeclampsia: prepare cohort study	2
Preeclampsia prediction with blood pressure measurements: A global external validation of the ALSPAC models	2
Patient knowledge, perceptions and follow up care of cardiovascular risk following HDP	2
Clinical study of fundoscopic findings in pregnancy induced hypertension	2
Clinical manifestations and complications of preeclampsia and eclampsia in populations residing at high altitudes and very high altitudes: A scoping review	2
Advancing machine learning tools for early prediction and clinical diagnosis of pre-eclampsia	2
Determinants of uncontrolled blood pressure among preeclamptic women receiving antihypertensive therapy in the South Gondar Zone, Northwest Ethiopia	2
Implementation of a novel surveillance and clinical decision support technology for the management of severe maternal hypertension	2
OP07_6. Hydroxychloroquine effect on endothelium – a role in the treatment of preeclampsia?	2
Editorial Board	2
PO1_11. Optimal timing of antenatal corticosteroid administration in pregnancies complicated by early-onset fetal growth restriction: The opticore study protocol	2
Withdrawn	2
Prediction of preeclampsia using first-trimester maternal serum Activin A levels: a prospective cohort study	2
Editorial Board	2
Galectin-7 dysregulates renin-angiotensin-aldosterone and NADPH oxide synthase pathways in preeclampsia	1
Study of the molecular basis of the human trophoblast	1
IL-1R1 signaling disrupts maternal immunotolerance, contributing to hypertension and fetal growth restriction in response to placental ischemia	1
Do commonly used antihypertensives affect fetal or neonatal heart rate? A systematic review of observational studies	1
Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial	1
PO7_6. CANCELLED : Test of scale of a novel vital signs alert device to improve maternity care in Sierra Leone: a qualitative evaluation of delivery and implementation	1
Nutricional intake, maternal outcomes and knowledge on preeclampsia prevention: Was there impact during the COVID-19 pandemic among women with hypertension?	1
Clinical factors associated with preeclampsia recurrence	1
Eclampsia in Italy: A prospective population-based study (2017–2020)	1
Maternal tumour necrosis factor-alpha levels in preeclamptic pregnancies in Lagos, South-West Nigeria	1
A Randomized control trial to compare the efficacy and Feto-maternal outcome of 75 Mg aspirin versus 150 Mg aspirin in women at high risk of pre-eclampsia	1
Patients and health care workers perceived challenges in managing preeclampsia, in Malawi	1
Differential platelet activation and thrombo-inflammatory mechanisms in early onset and late onset preeclampsia	1
PO9_03. Maternal ocular sonography: A window into the cerebral effects of antihypertensive therapy in preeclampsia	1
PO1_07. Non proteinuric preeclampsia: Implications in the diagnosis and clinical and laboratory profile with 2013[StQuote]s new diagnostic criteria	1
The role of serum uric acid levels in the evaluation and prediction of adverse outcomes in hypertensive disorders of pregnancy	1
Sleep disordered breathing and the risk of severe maternal morbidity in women with preeclampsia: A population-based study	1
Prevalence of perinatal mortality in hypertensive disorders of pregnancy	1
Postpartum clinic attendance, health services utilization and cardiometabolic screening in women with preeclampsia	1
Association of genetic ancestry with pre-eclampsia in multi-ethnic cohorts of pregnant women	1
Gut microbiota is different before the development of preeclampsia	1
Glycosylated fibronectin point-of-care test- role in prediction of pregnancy complications	1
Healthcare providers’ knowledge of cardiovascular disease risk after preeclampsia: A pilot of five healthcare facilities in Lusaka, Zambia	1
Nifedipine and the risk of adverse outcomes in hypertensive pregnancies complicated by fetal growth restriction	1
Alternative activation of macrophages driven by aberrantly decidualised endometrial stromal fibroblasts may be a pathogenic process during placentation in pre-eclampsia	1
Dynamic cerebral autoregulation in postpartum individuals with and without preeclampsia	1
OP04_6. The risk of new-onset neurological disorders after pregnancy-induced hypertension; a nation-wide register-based cohort study	1
Bioflavonoid luteolin inhibits relevant preeclamptic inflammatory and oxidative stress pathways in vitro	1
Clinical presentation and predictors of eclampsia among women with hypertensive disorders of pregnancy in Ghana	1
Artificial intelligence for non-invasive hemodynamic profiling in pregnancy: Development of a novel scoring system	1
Corrigendum to “First trimester preeclampsia screening and risk of placental lesions.” [Pregnancy Hypertens. 41 (2025) 101236]	1
Postpartum convulsion – An analysis	1
Placental and serum levels of human α-Klotho in preeclampsia & intra-uterine growth retardation: A potential sensitive biomarker?	1
Editorial Board	1
OP19_2. Luteolin, a natural flavonoid, attenuates the development of placental ischemia-induced hypertension in pregnant rats	1
Prediction of adverse neonatal outcome at admission for early-onset preeclampsia with severe features	1
Substantial decrease in preeclampsia prevalence and risk over two decades: A population-based study of 1,153,227 deliveries in Norway	1
Title Page	1
Factors associated with persistence of hypertension in patients with hypertensive disorders of pregnancy	1
Postpartum hemorrhage as a masquerader of Systemic Lupus Erythematosis (SLE)- An Obstetric Near Miss	1
PO3_16. Use of magnesium sulfate in preeclampsia - main maternal side effects	1
Early onset preeclampsia is associated with impairment of cyclic AMP signaling in trophoblasts	1
Preeclampsia biomarkers (sFlt-1/PlGF) dynamics are not disrupted by SARS-CoV-2 infection during pregnancy in a hypertensive disorder SARS-CoV-2 vaccinated cohort	1
Early magnesium discontinuation postpartum and eclampsia risk: A systematic review and meta-analysis	1
Methods matter: blood pressure variability and pregnancy outcomes	1
Low-dose aspirin potentially mitigates placental inflammation by increasing LXA4 and decreasing NLRP3 in an in vitro model of preeclampsia	1
Women’s childbirth experiences in the WILL randomised trial (when to induce labour to limit risk in pregnancy hypertension): a mixed methods analysis	1
Intrauterine exposure to hypertensive disorders of pregnancy and postnatal growth in extremely and very preterm infants	1
PO8_7. Short-chain fatty acid producing bacteria and butyrate levels are decreased in women who develop preeclampsia throughout gestation	1
PO6_13. Maternal biomarkers as a predictor for neonatal outcomes and timing of delivery	1
Pre-Eclampsia in pregnancy: A Knowledge, Attitude and Practice (KAP) Survey amongst specialists, junior residents and Primary Care Providers (PCPs) in India	1
Treatment of acute-onset hypertension in pregnancy: A network meta-analysis of randomized controlled trials comparing anti-hypertensives and route of administration	1
Is outpatient surveillance of preeclampsia without severe features still safe in contemporary obese Populations?	1
Use of non-invasive cardiac monitoring to guide discontinuation of postpartum magnesium sulfate in individuals with preeclampsia with severe features	1
Differences in disease severity and delivery gestational age between black and white patients with hypertensive disorders of pregnancy	1
PO6_23. Título evaluation of endothelial quality of blood vessels and arterial tone in pregnant women with hypertensive disorders	1
Understanding treatment resistance in preeclampsia: insights from sFlt-1 and plasma proteomics	1
Letter to Editor: Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complications	1
Intrapartum trends of NT-proBNP and hs-cTnT in patients with severe features of preeclampsia	1
Letter to the editor: Signs or symptoms of suspected preeclampsia – A retrospective national database study of prevalence, costs, and outcomes	1
OP05_3. Time-of-disease risk prediction of adverse maternal outcomes of pre-eclampsia using artificial intelligence	1
The role of the cerebro-placental-uterine ratio in predicting composite adverse perinatal outcomes in patients with pregnancy-induced hypertension	1
Circulating cardiovascular biomarkers during and after preeclampsia: Crosstalk with placental function?	1
Preeclampsia Education of the Nation (India), PEN(I): implementing educational models and global expansion strategies	1